Literature DB >> 22150449

Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa.

Judith A Hahn1, Loren M Dobkin, Bernard Mayanja, Nneka I Emenyonu, Isaac M Kigozi, Stephen Shiboski, David R Bangsberg, Heike Gnann, Wolfgang Weinmann, Friedrich M Wurst.   

Abstract

BACKGROUND: Alcohol is heavily consumed in sub-Saharan Africa and affects HIV transmission and treatment and is difficult to measure. Our goal was to examine the test characteristics of a direct metabolite of alcohol consumption, phosphatidylethanol (PEth).
METHODS: Persons infected with HIV were recruited from a large HIV clinic in southwestern Uganda. We conducted surveys and breath alcohol concentration (BRAC) testing at 21 daily home or drinking establishment visits, and blood was collected on day 21 (n = 77). PEth in whole blood was compared with prior 7-, 14-, and 21-day alcohol consumption.
RESULTS: (i) The receiver operator characteristic area under the curve (ROC-AUC) was highest for PEth versus any consumption over the prior 21 days (0.92; 95% confidence interval [CI]: 0.86 to 0.97). The sensitivity for any detectable PEth was 88.0% (95% CI: 76.0 to 95.6) and the specificity was 88.5% (95% CI: 69.8 to 97.6). (ii) The ROC-AUC of PEth versus any 21-day alcohol consumption did not vary with age, body mass index, CD4 cell count, hepatitis B virus infection, and antiretroviral therapy status, but was higher for men compared with women (p = 0.03). (iii) PEth measurements were correlated with several measures of alcohol consumption, including number of drinking days in the prior 21 days (Spearman r = 0.74, p < 0.001) and BRAC (r = 0.75, p < 0.001).
CONCLUSIONS: The data add support to the body of evidence for PEth as a useful marker of alcohol consumption with high ROC-AUC, sensitivity, and specificity. Future studies should further address the period and level of alcohol consumption for which PEth is detectable.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22150449      PMCID: PMC3310261          DOI: 10.1111/j.1530-0277.2011.01669.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  56 in total

1.  PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.

Authors:  Steina Aradottir; Gulber Asanovska; Stefan Gjerss; Per Hansson; Christer Alling
Journal:  Alcohol Alcohol       Date:  2006-04-19       Impact factor: 2.826

2.  South Africa: alcohol today.

Authors:  Charles D H Parry
Journal:  Addiction       Date:  2005-04       Impact factor: 6.526

3.  Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.

Authors:  Johanna Hietala; Heidi Koivisto; Petra Anttila; Onni Niemelä
Journal:  Alcohol Alcohol       Date:  2006-06-23       Impact factor: 2.826

Review 4.  Biomarkers in alcoholism.

Authors:  Onni Niemelä
Journal:  Clin Chim Acta       Date:  2006-09-05       Impact factor: 3.786

5.  Prevalence of psychoactive substance use among psychiatric in-patients in Harare, Zimbabwe.

Authors:  S W Acuda; M B Sebit
Journal:  Cent Afr J Med       Date:  1997-08

6.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

7.  Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption.

Authors:  Friedrich Martin Wurst; Sebastian Dresen; John P Allen; Gerhard Wiesbeck; Marc Graf; Wolfgang Weinmann
Journal:  Addiction       Date:  2006-02       Impact factor: 6.526

8.  Ethyl sulfate: a metabolite of ethanol in humans and a potential biomarker of acute alcohol intake.

Authors:  Anders Helander; Olof Beck
Journal:  J Anal Toxicol       Date:  2005 Jul-Aug       Impact factor: 3.367

9.  Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers.

Authors:  A Varga; P Hansson; C Lundqvist; C Alling
Journal:  Alcohol Clin Exp Res       Date:  1998-11       Impact factor: 3.455

10.  Phosphatidylethanol in human organs and blood: a study on autopsy material and influences by storage conditions.

Authors:  Steina Aradóttir; Stephan Seidl; Friedrich M Wurst; Bo A G Jönsson; Christer Alling
Journal:  Alcohol Clin Exp Res       Date:  2004-11       Impact factor: 3.455

View more
  64 in total

1.  An integrated videoconferencing intervention for chronic pain and heavy drinking among patients in HIV-care: a proof-of-concept study.

Authors:  Tibor P Palfai; Richard Saitz; Maya P L Kratzer; Jessica L Taylor; John D Otis; Judith A Bernstein
Journal:  AIDS Care       Date:  2020-06-11

2.  Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.

Authors:  Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2017-12-05       Impact factor: 3.455

3.  The Role of Alcohol-Related Behavioral Research in the Design of HIV Secondary Prevention Interventions in the Era of Antiretroviral Therapy: Targeted Research Priorities Moving Forward.

Authors:  Paul A Shuper
Journal:  AIDS Behav       Date:  2021-05-13

Review 4.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

5.  Declining and rebounding unhealthy alcohol consumption during the first year of HIV care in rural Uganda, using phosphatidylethanol to augment self-report.

Authors:  Judith A Hahn; Nneka I Emenyonu; Robin Fatch; Winnie R Muyindike; Allen Kekiibina; Adam W Carrico; Sarah Woolf-King; Stephen Shiboski
Journal:  Addiction       Date:  2015-11-05       Impact factor: 6.526

6.  The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV.

Authors:  Nikita Barai; Anne Monroe; Catherine Lesko; Bryan Lau; Heidi Hutton; Cui Yang; Anika Alvanzo; Mary Elizabeth McCaul; Geetanjali Chander
Journal:  AIDS Behav       Date:  2017-07

Review 7.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

8.  Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users.

Authors:  Jennifer Jain; Jennifer L Evans; Alya Briceño; Kimberly Page; Judith A Hahn
Journal:  Alcohol Alcohol       Date:  2014-06-17       Impact factor: 2.826

9.  Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda.

Authors:  Robin Fatch; Nneka I Emenyonu; Winnie Muyindike; Allen Kekibiina; Sarah Woolf-King; Judith A Hahn
Journal:  AIDS Behav       Date:  2017-07

Review 10.  The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review.

Authors:  Natalie E Kelso; David S Sheps; Robert L Cook
Journal:  Am J Drug Alcohol Abuse       Date:  2015-07-30       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.